These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8472742)

  • 1. Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.
    Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
    Eur J Pharmacol; 1993 Mar; 233(1):135-42. PubMed ID: 8472742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions.
    Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
    Eur J Pharmacol; 1992 Nov; 222(1):129-35. PubMed ID: 1468488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F; Chrapusta SJ; Egan MF
    J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
    Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
    Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
    Invernizzi R; Morali F; Pozzi L; Samanin R
    Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
    Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum.
    Egan MF; Karoum F; Wyatt RJ
    Eur J Pharmacol; 1991 Jun; 199(2):191-9. PubMed ID: 1954977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F; Achilli G; Perego C; Algeri S
    Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
    Rivest R; Marsden CA
    Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.
    Kehr W; Speckenbach W; Zimmermann R
    J Neural Transm; 1977; 40(2):129-47. PubMed ID: 323421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
    Westerink BH; Spaan SJ
    J Neurochem; 1982 Mar; 38(3):680-6. PubMed ID: 7057187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.
    Andén NE; Grabowska-Andén M; Liljenberg B
    J Neural Transm; 1983; 58(3-4):143-52. PubMed ID: 6420514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
    Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.
    Roth RH; Murrin LC; Walters JR
    Eur J Pharmacol; 1976 Mar; 36(1):163-71. PubMed ID: 177297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of morphine on dopamine metabolism in rat striatum and limbic structures in relation to the activity of dopaminergic neurones.
    Moleman P; van Valkenburg CF; vd Krogt JA
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):208-13. PubMed ID: 6493361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.